首页> 外文期刊>Addiction biology >MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats
【24h】

MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats

机译:MT-7716是一种有效的NOP受体激动剂,可优先减少依赖后大鼠的乙醇搜寻和增强

获取原文
获取原文并翻译 | 示例
           

摘要

Dysregulation of the nociceptin (N/OFQ) system has been implicated in alcohol abuse and alcoholism, and growing evidence suggests that targeting this system may be beneficial for treating alcoholism. To further explore the treatment target potential of the N/OFQ system, the novel non-peptide, small-molecule N/OFQ (NOP) agonist MT-7716, (R)-2-{3-[1-(Acenaphthen-1-yl)piperidin-4-yl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}-N-methylacetamide hydrochloride hydrate, was examined for its effects on ethanol self-administration and stress-induced reinstatement of alcohol seeking in non-dependent and post-dependent rats. Male Wistar rats were trained to self-administer ethanol and then made ethanol dependent via repeated intragastric ethanol intubation. The effects of MT-7716 (0.3 and 1mg/kg; PO) on alcohol self-administration were determined 2 weeks following dependence induction, when baseline self-administration was restored. Effects of MT-7716 on stress-induced reinstatement were tested in separate cohorts of rats, 1 and 3 weeks post-withdrawal. MT-7716 reduced alcohol self-administration and stress-induced reinstatement of alcohol seeking in post-dependent rats, but was ineffective in non-dependent animals. Moreover, the prevention of stress-induced reinstatement by MT-7716 was more pronounced at 3 weeks post-dependence. The results further confirm treatment target potential for the NOP receptor and identify non-peptide NOP agonists as promising potential treatment drugs for alcohol abuse and relapse prevention. The findings also support dysregulation of the N/OFQ system as a factor in alcohol seeking and reinforcement. Growing evidence suggests that targeting the nociceptin (N/OFQ) system may be beneficial for treating alcoholism. To further explore this hypothesis, the novel non-peptide (N/OFQ) NOP agonist MT-7716 was tested on ethanol self-administration and stress induced reinstatement of alcohol seeking in non-dependent and post-dependent rats. MT-7716 reduced alcohol self-administration and stress-induced reinstatement of alcohol seeking in post-dependent rats, but was ineffective in non-dependent animals. Results identify non-peptide NOP agonists as potential treatment drugs for alcohol abuse and relapse prevention.
机译:伤害感受素(N / OFQ)系统的失调与酒精滥用和酒精中毒有关,并且越来越多的证据表明,靶向该系统可能对治疗酒精中毒有益。为了进一步探索N / OFQ系统的治疗靶标潜力,新型非肽小分子N / OFQ(NOP)激动剂MT-7716,(R)-2- {3- [1-(Acenaphthen-1)考察了(-基)哌啶-4-基] -2-氧代-2,3-二氢-1H-苯并咪唑-1-基} -N-甲基乙酰胺盐酸盐水合物对乙醇自我给药和应激诱导的恢复的作用在非依赖和后依赖大鼠中寻找酒精对雄性Wistar大鼠进行训练,使其自我给药乙醇,然后通过重复进行胃内乙醇插管使乙醇依赖性。当恢复基线自我给药后,在依赖性诱导后2周确定MT-7716(0.3和1mg / kg; PO)对酒精自我给药的影响。在退出后1周和3周,在不同的大鼠组中测试了MT-7716对应激诱导的恢复的作用。 MT-7716在依赖后的大鼠中减少了酒精的自我给药和应激诱导的寻求酒精的恢复,但在非依赖动物中无效。此外,在依赖后3周,通过MT-7716预防压力诱导的恢复更为明显。结果进一步证实了NOP受体的治疗靶标潜力,并确定了非肽类NOP激动剂是有希望的潜在药物治疗滥用和预防复发。这些发现还支持N / OFQ系统失调,这是寻求和增强酒精的一个因素。越来越多的证据表明,靶向伤害感受素(N / OFQ)系统可能有助于治疗酒精中毒。为了进一步探索这一假设,在非依赖型和后依赖型大鼠中对乙醇的自我给药和应激诱导的酒精恢复进行了测试新型非肽(N / OFQ)NOP激动剂MT-7716。 MT-7716在依赖后的大鼠中减少了酒精的自我给药和应激诱导的寻求酒精的恢复,但在非依赖动物中无效。结果确定非肽NOP激动剂是用于酒精滥用和预防复发的潜在治疗药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号